REACT has landed to NephJC.
This time we explore rilparencel, an autologous kidney cell therapy injected directly into the renal cortex to slow kidney function decline in DKD and advanced CKD.
Is this the future of regenerative nephrology?
Take a look at the Visual Abstract Natalia Nombera and join the conversation on #NephJC.